0001127602-22-006283.txt : 20220223 0001127602-22-006283.hdr.sgml : 20220223 20220223162211 ACCESSION NUMBER: 0001127602-22-006283 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220221 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brennan Troyen A CENTRAL INDEX KEY: 0001351402 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 22664038 MAIL ADDRESS: STREET 1: AETNA INC. STREET 2: 151 FARMINGTON AVENUE CITY: HARTFORD STATE: CT ZIP: 06156 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-21 0000064803 CVS HEALTH Corp CVS 0001351402 Brennan Troyen A ONE CVS DRIVE WOONSOCKET RI 02895 1 EVP and Chief Medical Officer Common Stock 2022-02-21 4 A 0 171944 0 A 312815.059 D Common Stock (restricted) 4805 D Stock Option 104.82 2017-04-01 2023-04-01 Common Stock 53772 53772 D Stock Option 78.05 2018-04-03 2024-04-03 Common Stock 75134 75134 D Stock Option 62.21 2019-04-01 2025-04-01 Common Stock 21894 21894 D Stock Option 54.19 2020-04-01 2029-04-01 Common Stock 80803 80803 D Stock Option 58.34 2021-04-01 2030-04-01 Common Stock 84478 84478 D Stock Option 74.30 2022-04-01 2031-04-01 Common Stock 99344 99344 D Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Option became exercisable in four equal annual installments, commencing 4/1/2017. Option became exercisable in four equal annual installments, commencing 4/3/2018. Option became exercisable in four equal annual installments, commencing 4/1/2019. Option became exercisable in four equal annual installments, commencing 4/1/2020. The number of shares subject to the option were calculated using a 30-day average price. Options became exercisable in four equal annual installments, commencing 4/1/2021. Option becomes exercisable in four equal annual installments, commencing 4/1/2022. /s/ Troyen Brennan 2022-02-23